
Sotagliflozin effective in treating patients with type 1 diabetes.

Sotagliflozin effective in treating patients with type 1 diabetes.

Findings presented at ADA conference highlight effiacy of insulin glargine/lixisenatide combination.

Patients who switched to insulin glargine were 57% less likely to experience hypoglycemia.

Lennox-Gastaut syndrome is a severe form of epilepsy that begins in childhood.

April 24th 2017